tradingkey.logo

Treace Medical Concepts Inc

TMCI
2.260USD
+0.220+10.78%
Close 02/06, 16:00ETQuotes delayed by 15 min
143.97MMarket Cap
LossP/E TTM

Treace Medical Concepts Inc

2.260
+0.220+10.78%

More Details of Treace Medical Concepts Inc Company

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.

Treace Medical Concepts Inc Info

Ticker SymbolTMCI
Company nameTreace Medical Concepts Inc
IPO dateApr 23, 2021
CEOTreace (John T)
Number of employees477
Security typeOrdinary Share
Fiscal year-endApr 23
Address100 Palmetto Park Place
CityPONTE VEDRA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code32081
Phone19043735940
Websitehttps://www.treace.com/
Ticker SymbolTMCI
IPO dateApr 23, 2021
CEOTreace (John T)

Company Executives of Treace Medical Concepts Inc

Name
Name/Position
Position
Shareholding
Change
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+23917.00%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
378.40K
+316000.00%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
273.50K
+248505.00%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+23917.00%
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
Ms. Elizabeth S. (Betsy) Hanna
Ms. Elizabeth S. (Betsy) Hanna
Independent Director
Independent Director
--
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Ms. Jane E. Kiernan
Ms. Jane E. Kiernan
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+23917.00%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
378.40K
+316000.00%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
273.50K
+248505.00%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+23917.00%
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sun, Feb 1
Updated: Sun, Feb 1
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Treace (John T.)
18.72%
Armistice Capital LLC
9.91%
William Blair Investment Management, LLC
5.70%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
3.57%
Other
56.99%
Shareholders
Shareholders
Proportion
Treace (John T.)
18.72%
Armistice Capital LLC
9.91%
William Blair Investment Management, LLC
5.70%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
3.57%
Other
56.99%
Shareholder Types
Shareholders
Proportion
Individual Investor
27.21%
Investment Advisor/Hedge Fund
22.63%
Hedge Fund
19.26%
Investment Advisor
15.78%
Research Firm
2.22%
Venture Capital
0.93%
Bank and Trust
0.32%
Pension Fund
0.04%
Family Office
0.03%
Other
11.58%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
332
38.84M
60.95%
-15.62M
2025Q3
338
38.30M
60.11%
-18.99M
2025Q2
369
55.28M
87.88%
-20.58M
2025Q1
378
54.40M
86.48%
-21.10M
2024Q4
366
54.35M
86.91%
-21.27M
2024Q3
360
58.92M
95.05%
-18.98M
2024Q2
346
57.87M
93.51%
-12.18M
2024Q1
319
59.01M
95.72%
-10.84M
2023Q4
318
57.97M
94.48%
-4.76M
2023Q3
299
57.85M
94.48%
-5.12M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Treace (John T.)
11.70M
18.37%
-159.07K
-1.34%
Mar 24, 2025
Armistice Capital LLC
6.32M
9.91%
+56.00K
+0.89%
Sep 30, 2025
William Blair Investment Management, LLC
3.63M
5.7%
+534.49K
+17.24%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.26M
5.11%
-26.43K
-0.80%
Sep 30, 2025
The Vanguard Group, Inc.
2.73M
4.29%
+6.24K
+0.23%
Sep 30, 2025
Gagnon Securities LLC
2.26M
3.54%
+8.09K
+0.36%
Sep 30, 2025
Treace (James T)
1.78M
2.79%
--
--
Mar 24, 2025
Millennium Management LLC
1.71M
2.68%
+192.93K
+12.72%
Sep 30, 2025
CIBC Private Wealth Management
1.69M
2.65%
-1.00K
-0.06%
Sep 30, 2025
First Eagle Investment Management, L.L.C.
1.24M
1.94%
+330.87K
+36.44%
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares U.S. Medical Devices ETF
0.04%
Franklin US Small Cap Multifactor Index ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Fidelity Enhanced Small Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Morningstar Small-Cap ETF
0%
View more
iShares U.S. Medical Devices ETF
Proportion0.04%
Franklin US Small Cap Multifactor Index ETF
Proportion0.04%
iShares Russell 2000 Growth ETF
Proportion0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.01%
Schwab U.S. Small-Cap ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
Fidelity Enhanced Small Cap ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
iShares Morningstar Small-Cap ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI